Analytical methods knowledge base
How to Read a Peptide Certificate of Analysis
A field-by-field framework for checking lot identity, specification, method references, results, approval status and document scope without treating the COA as broader evidence than it is.
Method-aware interpretation
Read the result as a chain of evidence.
Each section connects the analytical question, reporting basis and conclusion boundary.
Start with traceability, not the largest number
A useful COA identifies the product, lot or batch, material form, test dates or release context and the organization issuing the record. The product label and supplied container should match the document. A polished PDF with no lot linkage is not lot-specific evidence.
- Match catalog number, material name, lot number and salt or counterion form.
- Check whether the document is a specification sheet, representative report or released-lot COA.
- Confirm revisions or replacements have not changed the applicable result.
Read each row as specification, method and result
The specification states the acceptance criterion; the method states how the attribute is evaluated; the result states what was observed for the lot. “Conforms” can be appropriate for a qualitative test, but a quantitative claim should preserve the numerical result and basis when those details are material to the decision.
- Do not confuse a target specification with an actual result.
- Look for units, basis and significant figures.
- Request clarification when identity, purity and content are collapsed into one ambiguous line.
Recognize the document boundary
A COA supports only the attributes tested under the stated procedures and conditions. It does not by itself establish clinical safety, efficacy, legal eligibility for a destination, sterility, endotoxin status or long-term stability unless those matters are specifically addressed by valid evidence.
- Use a separate stability record for shelf-life or storage claims.
- Use applicable microbiological records for bioburden, sterility or endotoxin questions.
- Verify electronic signatures, approval roles and issue dates when document control matters.
Decision table
What the field means—and what it does not prove
Use this table to prevent a valid analytical result from being expanded beyond its intended purpose.
↔ Swipe horizontally to read every column
| Record or question | What it can support | What it does not prove |
|---|---|---|
| Specification | Predefined acceptance criterion | That the lot was actually tested or passed |
| Result | Recorded outcome for the identified sample or lot | Attributes outside the method scope |
| Approved by | Document release or review role | Independent regulatory endorsement |
Interpretation limits
Stop where the method stops.
- Representative or template COAs must not be presented as lot-specific documents.
- A COA cannot cure an ambiguous product identity.
- Document authenticity and applicable quality-system controls require supplier-level verification.
Primary and technical sources
Records used for this guide
Sources are linked directly so the wording, date and scope can be checked independently.
- 01Source record
ICH Q6A: Specifications—Test Procedures and Acceptance Criteria
International Council for Harmonisation. Step 4 guideline, October 1999.
- 02Source record
Analytical Procedures and Methods Validation for Drugs and Biologics
U.S. Food and Drug Administration. Guidance for Industry, July 2015.
- 03Source record
Bulk Drug Substances Used in Compounding Under Section 503A
U.S. FDA. Current compounding policy page; notes that applicable bulk substances must be accompanied by a valid certificate of analysis.
Knowledge center